Senores Pharmaceuticals Limited has informed the Exchange regarding update in terms of Regulation 30(5) of SEBI (LODR) Regulations, 2015
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Senores Pharmaceuticals has submitted a routine compliance update to the stock exchange under Regulation 30(5) of the SEBI (LODR) Regulations, 2015. This regulation requires listed companies to disclose details of their key managerial personnel or other authorized persons responsible for determining materiality of events and communicating disclosures to stock exchanges. The filing is procedural in nature and typically involves updating the names and contact details of officials authorized to make such disclosures on behalf of the company. No financial numbers, business events, or corporate actions are mentioned in the headline.
This is a standard regulatory housekeeping update with no material impact on the company's business, financials, or stock price. Shareholders need not take any action.